Designed to assist cytology labs in detecting abnormal cells and organisms quickly and accurately, our cytology solutions aim to improve efficiency and patient outcomes.
Cytology
Challenges & Solution
Cytology presents several challenges, including a shortage of cytotechnologists, colocation of slides and reviewers, and the physical discomforts of looking through a microscope all day.
Techcyte’s SureView™ system is designed to enhance efficiency by digitizing the slides, and enabling an AI-assisted analysis to pre-screen BD SurePath™ and ThinPrep® slides, flagging areas of interest for cytotechnologists to review.
Techcyte reduces microscope time, enables remote review, and integrates with the LIS for reporting.
Partnership
BD
We’ve collaborated to provide a complete cervical cytology solution that leverages AI-based technology, whose goal is to increase efficiency and standardization while addressing the global shortage of skilled cytotechnologists.
CorePlus
After more than two years of clinical collaboration CorePlus is the first laboratory in the world to operationalize the Techcyte AI algorithm and quality control workflow for cytology-based cervical cancer screening.
Related resources
- ESP
BD, Techcyte Announce Strategic Collaboration to Offer AI-Based Digital Cervical Cytology System
Feb 2024 - Press Release
Austria’s Tyrolpath Leads Europe with First Clinical Adoption of Techcyte SureView™
Jun 2025 - Press + events
Implementing 100% QC in a Cervical Cytology Workflow Using WSI and AI
Mar 2025 - Publications
Implementing 100% quality control in a cervical cytology workflow using whole slide images and artificial intelligence provided by the Techcyte SureView™ System
May 2025 - Press Release
Pramana and Techcyte Form Strategic Collaboration to Offer AI-powered Scanning Technology for Cytology & Microbiology Applications
Oct 2023 - Press Release
Techcyte receives UKCA registration for Gram stain, fecal wet mount, AFB, cervical cytology, and more
Sep 2025 - Press Release
CorePlus Deploys the Techcyte AI Algorithm for 100% QC of Pap Tests
May 2024 - Press Release
Techcyte Secures Patent to Increase Detection of Cancer in Pap Smears
May 2020